Response to Comment on Bezin et al. GLP-1 Receptor Agonists and the Risk of Thyroid Cancer. Diabetes Care 2023;46:384-390

Diabetes Care. 2023 May 1;46(5):e121-e122. doi: 10.2337/dci23-0016.

Julien Bezin^{1

2}, Clément Mathieu², Jean-Luc Faillie^{3

4}, Antoine Pariente^{1

2}

¹ 1Service de Pharmacologie, Pôle de Santé Publique, Centre Hospitalier Universitaire de Bordeaux, Bordeaux, France.
² 2Pharmacoepidemiology Team, UMR 1219 Bordeaux Population Health Research Center, INSERM, University of Bordeaux, Bordeaux, France.
³ 3Département de Pharmacologie Médicale et Toxicologie, Centre Hospitalier Universitaire de Montpellier, Montpellier, France.
⁴ 4Desbrest Institute of Epidemiology and Public Health, University of Montpellier, INSERM, Montpellier, France.

No abstract available

Publication types